The compounding pharmacies market has been bifurcated in terms of product, therapeutic area, application, sterility, compounding type, distribution channel, and region.
©2022AllRightsReserved www.gminsights.com
Global Market Insights recently introduced report on Global Compounding Pharmacies Market Report is an in depth study providing complete analysis of the industry for the period 2022 to 2030. It provides complete overview of Global Compounding Pharmacies industry considering all the major industry trends, market dynamics and competitive scenario.
Moreover, key players in the market have been engaging in rigorous R&D and strategic acquisitions and collaborations to expand their customer base and improve their industry standing. For instance, in March 2022, B. Braun, a German medical and pharmaceutical company, acquired Intermedt Medizin & Technik GmbH, an expert in the preparation of dialysis concentrates. The acquisition was intended to aid the company in expanding its business in the field of dialysis concentrates.
The compounding pharmacies market is speculated to grow massively by 2030 owing to widespread adoption of customized medicine in developed regions. In addition, expanding geriatric population, along with a shortage of drugs, is likely to further propel market growth through the forecast period.
Compounding Pharmacies Market, Share, Growth, Trends and Forecast to 2030: Global Market Insights
along with the table of contents: https://www.gminsights.com/industry-analysis/compounding-pharmacies-market
The emergence of the COVID 19 pandemic provided the industry with new opportunities to prosper in recent years. Increasing demand for medications from hospital and compounding pharmacies to curb the spread of the coronavirus infection escalated the utilization of compounded drugs. Furthermore, government authorization to maintain the availability of these drugs aided market expansion.
Browse key industry insights spread across 530 pages with 939 market data tables &24 figures & charts from the report, “Compounding Pharmacies Market Analysis, By Therapeutic Area (Nutritional Supplements, Hormone Replacement, Dermatology, Pain Management, Specialty Drugs), By Product (Liquid Preparations [Solutions, Emulsion, TrendPharmacy)SterilityPharmaceutCompoundingNasal,{Ointments,Suspension,Syrup],Oral{SolidPreparations[Tablets,Granules,Capsules,Powder]},TopicalGels,Creams,Pastes},Parenteral{LVP,SVP},Rectal{Enema,Suppositories},Otic,Ophthalmic,),ByApplication(Pediatric,Geriatric,Adult,Veterinary),ByType(PharmaceuticalDosageAlteration[PDA],CurrentlyUnavailableicalManufacturing[CUPM],PharmaceuticalIngredientAlteration[PIA]),By(Non-sterile,Sterile),ByDistributionChannel(CompoundingPharmacy,HospitalRegionalOutlook,Covid-19ImpactAnalysis,IndustryAnalysisReport,Prices,GrowthPotential,CompetitiveMarketShare&Forecast,2022 2030” in detail
With respect to therapeutic area, the industry has been divided into nutritional supplements, hormone replacement, dermatology, pain management, specialty drugs, and others. The dermatology segment is expected to grow at approximately 6.4% CAGR over the analysis timeframe. Growing skin related concerns viz., skin aging and sunburns, coupled with soaring need for healthy skin, are major factors that are poised to drive the demand for compounding medicines for dermatological usage. Additionally, the ability of compounded dermatological drugs to accommodate individual needs and overcome issues related to allergies and sensitivities caused by commercially available skin care medications is set to boost segmental
Theprogress.compounding
pharmacies market has been classified based on product into oral, topical, parenteral, rectal, nasal, otic, and ophthalmic. The topical segment size was registered at over $1,727.2 million in 2021 and is slated to attain substantial gains by 2030. The growth is attributed to ease of drug delivery, drug formulations, and rising demand for ointments, gels, creams, patches, lotions, and sprays, especially for pain management owing to their faster action at the site of application. Moreover, prominent R&D activities for the development of innovative topical medications using compounding pharmacies to cater to specific patient requirements are also projected to propel segmental expansion.
From application point of reference, the compounding pharmacies market has been segregated into pediatric, geriatric, adult, and veterinary. In 2021, the pediatric segment accounted for above $1,653.2 million valuation and is estimated to record significant expansion in the coming years. Several benefits of compounded medications, such as dose alteration, ingredient alteration, and the advantage of altering the route of administration, are likely to increase the demand for compounded medications for pediatric usage.
©2022AllRightsReserved www.gminsights.com
ChapterPartialTableofContents(ToC)ofthereport:4CompoundingPharmaciesMarket,ByTherapeuticArea 4.1 Key segment trends 4.2 Hormone replacement 4.2.1 Market size, by region, 2017 2030 (USD Million) 4.3 Pain management 4.3.1 Market size, by region, 2017 2030 (USD Million) 4.4 Dermatology applications 4.4.1 Market size, by region, 2017 2030 (USD Million) 4.5 Specialty drugs 4.5.1 Market size, by region, 2017 2030 (USD Million) 4.6 Nutritional supplements
4.7.1 Market size, by region, 2017 2030 (USD Million)
5.2.2 Solid preparations
5.2.2.6.1 Market size, by region, 2017 2030 (USD Million)
5.2.2.5 5.2.2.5.1PowderMarket size, by region, 2017 2030 (USD Million)
5.2.2.3 5.2.2.3.1CapsulesMarket size, by region, 2017 2030 (USD Million)
©2022AllRightsReserved www.gminsights.com
5.1 Key segment trends
5.2.2.6 Others
5.2.3.1 Market size, by region, 2017 2030 (USD Million)
4.6.1 Market size, by region, 2017 2030 (USD Million)
5.2.2.1 Market size, by region, 2017 2030 (USD Million)
5.2.3.3.1 Market size, by region, 2017 2030 (USD Million)
5.2.3 Liquid preparations
5.2.1 Market size, by region, 2017 2030 (USD Million)
5.2 Oral
5.2.3.2 5.2.3.2.1SolutionMarket size, by region, 2017 2030 (USD Million)
5.2.3.3 Suspension
5.2.2.2 5.2.2.2.1TabletsMarket size, by region, 2017 2030 (USD Million)
4.7 Others
Chapter5 CompoundingPharmaciesMarket,ByProduct
5.2.3.4 5.2.3.4.1EmulsionMarket size, by region, 2017 2030 (USD Million)
5.2.2.4 5.2.2.4.1GranulesMarket size, by region, 2017 2030 (USD Million)
5.3.3.1 Market size, by region, 2017 2030 (USD Million)
5.3.3 Creams
5.2.3.5
5.3 Topical
5.3.2 Ointments
5.3.6.1 Market size, by region, 2017 2030 (USD Million)
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
5.2.3.5.1SyrupMarket size, by region, 2017 2030 (USD Million)
Contact Us:
5.3.6 Others
5.3.5.1 Market size, by region, 2017 2030 (USD Million)
©2022AllRightsReserved www.gminsights.com
5.3.4.1 Market size, by region, 2017 2030 (USD Million)
5.3.1 Market size, by region, 2017 2030 (USD Million)
Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/compounding pharmacies market
5.3.5 Pastes
5.2.3.6 5.2.3.6.1OthersMarket size, by region, 2017 2030 (USD Million)
5.3.4 Gels
5.3.2.1 Market size, by region, 2017 2030 (USD Million)
TollFree: +1 888 689 0688
Europe: +44 742 759 8484
APAC: +65 3129 7718
©2022AllRightsReserved www.gminsights.com
Global Market Insights Inc.
Aashit CorporateTiwariSales, USA
Email: sales@gminsights.com
USA: +1 302 846 7766